Supreme Court Rejects J&J Bid to Overturn $302M Vaginal Mesh Lawsuit Award
The Supreme Court has denied a Johnson & Johnson petition to review a $302 million verdict won by the state of California over the company's marketing of its vaginal mesh…
The Supreme Court has denied a Johnson & Johnson petition to review a $302 million verdict won by the state of California over the company's marketing of its vaginal mesh…
Researchers warn that FDA devices fast-tracked through the approval process are often based on older devices which were recalled themselves, increasing the chances of the new device also being recalled…
After reviewing the final postmarketing study on Coloplast transvaginal mesh, the FDA has determined the risks still outweigh the potential benefits.
A transvaginal mesh lawsuit has been filed over an Ethicon Gynecare mesh which eroded through a woman's flesh
New postmarketing surveillance studies show Boston Scientific transvaginal mesh increase the risk of health complications for pelvic organ prolapse patients, without adding any additional effectiveness or safety over traditional surgical…
Boston Scientific will pay $187 million to resolve claims by most states that it misled both women and state health agencies over the safety and efficacy of transvaginal mesh products.
C.R. Bard will pay $60 million to resolve claims with most states that its transvaginal mesh products were deceptively advertised.
A California judge wants Johnson & Johnson to pay $344 million to the state for falsely advertising the safety of its vaginal mesh products.
Complications from transvaginal mesh may cause severe injuries.
Johnson & Johnson and Ethicon have agreed to pay 41 states nearly $117 million to settle charges of deceptive marketing and defrauding state health care systems over the safety and…